Teladoc Health (TDOC) Gains from Investment Securities (2013 - 2026)

Teladoc Health has disclosed Gains from Investment Securities across 14 years of filings, most recently posting -$42000.0 for Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at -$42000.0, down 112.8% year-over-year; the trailing twelve-month figure through Mar 2026 was -$6.8 million (down 163.4% YoY), and the FY2025 annual result was -$6.4 million, down 171.53% from the prior year.
• Gains from Investment Securities came in at -$42000.0 for Q1 2026 at Teladoc Health, up from -$6.3 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $8.9 million in Q4 2024 to a low of -$12.0 million in Q4 2023.
• The 5-year median for Gains from Investment Securities is $198880.5 (2022), against an average of $104392.3.
• Peak annual rise in Gains from Investment Securities reached 7829.93% in 2023, while the deepest fall reached 201.72% in 2023.
• Teladoc Health's Gains from Investment Securities stood at $69761.0 in 2022, then tumbled by 17314.49% to -$12.0 million in 2023, then jumped by 174.49% to $8.9 million in 2024, then tumbled by 170.86% to -$6.3 million in 2025, then soared by 99.34% to -$42000.0 in 2026.
• The last three Gains from Investment Securities figures came in at -$42000.0 (Q1 2026), -$6.3 million (Q4 2025), and -$388000.0 (Q2 2025), per Business Quant data.